Global Glucose Biosensors Market Growth 2025-2031

Global Glucose Biosensors Market Growth 2025-2031

The global Glucose Biosensors market size is predicted to grow from US$ 3347 million in 2025 to US$ 3672 million in 2031; it is expected to grow at a CAGR of 1.6% from 2025 to 2031.

The biosensor is a sensing device, which consists of a combination of a specific biological element and a transducer. Biosensors are defined as analytical devices that convert a biological response into electrical signal and assist in measuring a wide spectrum of analytes including organic compounds, gases, bacteria and others.

The top four manufacturers are Roche, LifeScan, Bayer and Abbott. They have dominated the global market by 57% market shares. Other key manufacturers include ARKRAY, Omron, Dexcom, AgaMatrix, B. Braun, i-SENS and Chinese companies like SANNUO, YICHENG and Yuwell,etc.

LP Information, Inc. (LPI) ' newest research report, the “Glucose Biosensors Industry Forecast” looks at past sales and reviews total world Glucose Biosensors sales in 2024, providing a comprehensive analysis by region and market sector of projected Glucose Biosensors sales for 2025 through 2031. With Glucose Biosensors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucose Biosensors industry.

This Insight Report provides a comprehensive analysis of the global Glucose Biosensors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucose Biosensors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glucose Biosensors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucose Biosensors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucose Biosensors.

This report presents a comprehensive overview, market shares, and growth opportunities of Glucose Biosensors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Self-monitoring of Blood Glucose (SMBG)
Continuous Glucose Monitoring

Segmentation by Application:
Homecare Diagnostics
Hospitals
Diagnostic Centers, Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
LifeScan
Bayer
Abbott
ARKRAY
Omron
I-SENS
B. Braun
Dexcom
AgaMatrix
SANNUO
YICHENG
Yuwell
Andon Health
Yingke

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucose Biosensors market?

What factors are driving Glucose Biosensors market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glucose Biosensors market opportunities vary by end market size?

How does Glucose Biosensors break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.